News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
535,069 Results
Type
Article (21545)
Company Profile (224)
Press Release (513190)
Multimedia
Podcasts (245)
Webinars (21)
Section
Business (182934)
Career Advice (1062)
Deals (28307)
Drug Delivery (122)
Drug Development (61260)
Employer Resources (145)
FDA (11033)
Job Trends (10442)
News (263202)
Policy (21011)
Tag
2027 BioMidwest Elite (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (2)
2027 Genetown Elite (3)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (923)
Academic (1)
Accelerated approval (39)
ADA (27)
Adcomms (18)
Allergies (120)
Alliances (37463)
ALS (147)
Alzheimer's disease (1231)
Antibody-drug conjugate (ADC) (381)
Approvals (11409)
Artificial intelligence (555)
ASCO (213)
Autoimmune disease (261)
Automation (39)
Bankruptcy (303)
Best Places to Work (7575)
BIO (81)
Biologics (3)
BIOSECURE Act (17)
Biosimilars (158)
BioSpace Insights (236)
Biotechnology (140)
Bispecific (1)
Bladder cancer (151)
Brain cancer (42)
Breast cancer (567)
Cancer (4327)
Cardiovascular disease (330)
Career advice (931)
Career pathing (42)
CAR-T (248)
CDC (31)
CDMO (130)
Celiac Disease (2)
Cell therapy (711)
Cervical cancer (36)
Clinical research (53476)
Collaboration (1616)
Commercialization (7)
Company closure (8)
Compensation (1499)
Complete response letters (57)
COVID-19 (1904)
CRISPR (96)
C-suite (972)
Cystic fibrosis (105)
Data (6206)
Decentralized trials (2)
Denatured (101)
Depression (139)
Dermatology (66)
Diabetes (416)
Diagnostics (4679)
Digital health (43)
Diversity (12)
Diversity, equity & inclusion (41)
Drug discovery (278)
Drug pricing (94)
Drug shortages (14)
Duchenne muscular dystrophy (228)
Earnings (76537)
Editorial (56)
Employer branding (22)
Employer resources (120)
Events (95279)
Executive appointments (847)
FDA (13878)
Fibrodysplasia Ossificans Progressiva (9)
Fragile X (1)
Friedreich's ataxia (22)
Frontotemporal dementia (26)
Funding (1342)
Gene editing (193)
Generative AI (49)
Gene therapy (559)
GLP-1 (691)
Government (1907)
Grass and pollen (3)
Guidances (294)
Healthcare (10335)
Hematology (109)
HIV (61)
Huntington's disease (45)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (87)
Immunology and inflammation (212)
Immuno-oncology (80)
Indications (166)
Infectious disease (2139)
Inflammatory bowel disease (148)
Inflation Reduction Act (13)
Influenza (99)
Intellectual property (279)
Interviews (170)
IPO (13234)
IRA (27)
Job creations (3007)
Job search strategy (812)
JPM (61)
Kidney cancer (16)
Labor market (128)
Layoffs (375)
Leadership (25)
Legal (5882)
Licensing (12)
Liver cancer (62)
Longevity (29)
Lung cancer (610)
Lymphoma (283)
Machine learning (45)
Management (35)
Manufacturing (852)
Marketing (9)
MASH (161)
Medical device (9096)
Medtech (9252)
Mergers & acquisitions (16166)
Metabolic disorders (1080)
mRNA (226)
Multiple sclerosis (121)
Multispecific (1)
NASH (12)
Neurodegenerative disease (326)
Neuropsychiatric disorders (69)
Neuroscience (2334)
Neurotech (1)
NextGen: Class of 2026 (3984)
Non-profit (1077)
Now hiring (83)
Obesity (455)
Opinion (211)
Ovarian cancer (174)
Pain (191)
Pancreatic cancer (236)
Parkinson's disease (236)
Partnered (35)
Patents (531)
Patient advocacy (1)
Patient recruitment (576)
Peanut (35)
People (45972)
Pharmaceutical (43)
Pharmacy benefit managers (16)
Phase 1 (17386)
Phase 2 (24102)
Phase 3 (16752)
Pipeline (8100)
Policy (233)
Postmarket research (1671)
Preclinical (7312)
Press Release (47)
Prostate cancer (211)
Psychedelics (60)
Radiopharmaceuticals (241)
Rare diseases (873)
Real estate (3914)
Recruiting (55)
Regulatory (17178)
Reports (77)
Research institute (967)
Resumes & cover letters (154)
Rett syndrome (45)
RNA editing (22)
RSV (57)
Schizophrenia (123)
Series A (262)
Series B (191)
Service/supplier (6)
Sickle cell disease (84)
Special edition (32)
Spinal muscular atrophy (106)
Sponsored (31)
Startups (2884)
State (1)
Stomach cancer (7)
Supply chain (79)
Tariffs (33)
The Weekly (141)
Vaccines (841)
Venture capital (125)
Weight loss (262)
Women's health (105)
Worklife (20)
Date
Last 7 days (291)
Last 30 days (1629)
Last 365 days (21698)
2026 (14491)
2025 (21819)
2024 (25940)
2023 (29602)
2022 (38607)
2021 (41001)
2020 (36502)
2019 (26109)
2018 (19577)
2017 (21982)
2016 (21355)
2015 (26994)
2014 (23784)
2013 (19818)
2012 (21884)
2011 (22021)
2010 (21655)
Location
Africa (514)
Alabama (79)
Alaska (2)
Arizona (315)
Arkansas (12)
Asia (24433)
Australia (3111)
California (12795)
Canada (3313)
China (850)
Colorado (507)
Connecticut (447)
Delaware (262)
Europe (37643)
Florida (1851)
Georgia (395)
Hawaii (4)
Idaho (51)
Illinois (815)
India (74)
Indiana (344)
Iowa (19)
Japan (446)
Kansas (115)
Kentucky (35)
Louisiana (33)
Maine (27)
Maryland (1294)
Massachusetts (8566)
Michigan (320)
Minnesota (635)
Mississippi (5)
Missouri (93)
Montana (21)
Nebraska (14)
Nevada (147)
New Hampshire (70)
New Jersey (2781)
New Mexico (22)
New York (2980)
North Carolina (1386)
North Dakota (5)
Northern California (6427)
Ohio (333)
Oklahoma (16)
Oregon (21)
Pennsylvania (2389)
Puerto Rico (23)
Rhode Island (36)
South America (681)
South Carolina (79)
South Dakota (1)
Southern California (5206)
Tennessee (129)
Texas (2119)
United States (41669)
Utah (412)
Vermont (1)
Virginia (174)
Washington D.C. (52)
Washington State (979)
West Virginia (2)
Wisconsin (82)
Wyoming (1)
535,069 Results for "isolere bio inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Isolere Bio by Donaldson Passes Most Significant Milestone To-Date, Announces Availability of Manufacturing-Grade IsoTag™ AAV Reagent
April 24, 2025
·
4 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Deals
Donaldson Acquires Isolere Bio, Continuing to Build Life Sciences Business
Donaldson Company, Inc. announced the acquisition of Isolere Bio, Inc., an early-stage biotechnology company that develops novel and proprietary IsoTag™ reagents and accompanying filtration processes used for the purification and streamlined manufacturing of biopharmaceuticals.
February 21, 2023
·
4 min read
Press Releases
BIO 2026 – Cytomos showcases groundbreaking new digital platform AuraCyt®, which enables earlier, smarter bioprocessing decisions
At this year’s annual meeting of the Bio International Convention (BIO) in San Diego, CA, TechBio company Cytomos (www.cytomos.com) is showcasing their flagship cell analytic intelligence platform AuraCyt® – together with its novel benchtop technology Celledonia® – which is set to revolutionise predictive cell analytics.
June 22, 2026
·
1 min read
Press Releases
Johnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation
July 29, 2026
·
6 min read
Press Releases
INmune Bio Inc. Achieves MHRA Approval of PIP for CORDStrom™
June 25, 2026
·
7 min read
Press Releases
Valion Bio Announces Reverse Stock Split
August 27, 2026
·
7 min read
Press Releases
INmune Bio Inc. Announces Second Quarter 2026 Results and Highlights Regulatory, Manufacturing and Clinical Progress
August 7, 2026
·
13 min read
China
BIO 2026: US needs to dodge China’s ‘inescapable dependencies’ to protect biotech
Speaking to media on Tuesday, BIO CEO John Crowley complimented China’s rise as a biotech powerhouse but said U.S. policy needs to protect and maintain America’s lead.
June 24, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.
July 29, 2026
·
6 min read
1 of 53,507
Next
